Question 1

Was ist der Wirkstoff in Autologous CD34+ enriched cell fraction that contains CD34+ cells transduced with retroviral vector that encodes for the human ADA cDNA sequence?

Accepted Answer

Autologous CD34+ enriched cell fraction that contains CD34+ cells transduced with retroviral vector that encodes for the human ADA cDNA sequence

Question 2

In welcher Darreichungsform ist Autologous CD34+ enriched cell fraction that contains CD34+ cells transduced with retroviral vector that encodes for the human ADA cDNA sequence erhältlich?

Accepted Answer

Autologous CD34+ enriched cell fraction that contains CD34+ cells transduced with retroviral vector that encodes for the human ADA cDNA sequence: Dispersion for infusion (Intravenous use)

Question 3

Wer stellt Autologous CD34+ enriched cell fraction that contains CD34+ cells transduced with retroviral vector that encodes for the human ADA cDNA sequence her?

Accepted Answer

Fondazione Telethon ETS (BE)

Question 4

Zu welcher ATC-Klasse gehört Autologous CD34+ enriched cell fraction that contains CD34+ cells transduced with retroviral vector that encodes for the human ADA cDNA sequence?

Accepted Answer

Autologous CD34+ enriched cell fraction that contains CD34+ cells transduced with retroviral vector that encodes for the human ADA cDNA sequence: ATC L03AX Other Immunostimulants. ATC ist die anatomisch-therapeutisch-chemische WHO-Klassifikation — gruppiert Medikamente nach Organsystem und Wirkmechanismus.

Autologous CD34+ enriched cell fraction that contains CD34+ cells transduced with retroviral vector that encodes for the human ADA cDNA sequence

Nutzerbewertungen